| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/26/2002 | WO2002074763A1 Benzimidazol derivatives modulate chemokine receptors |
| 09/26/2002 | WO2002074762A1 Process for producing sulfone derivative |
| 09/26/2002 | WO2002074761A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 09/26/2002 | WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 09/26/2002 | WO2002074753A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 09/26/2002 | WO2002074752A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074751A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074750A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074749A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074748A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074747A1 Farnesyltransferase inhibitors |
| 09/26/2002 | WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same |
| 09/26/2002 | WO2002074741A1 Pyrrolidine ester derivatives with oxytocin modulating acitvity |
| 09/26/2002 | WO2002074735A2 Biurethane derivatives |
| 09/26/2002 | WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6? |
| 09/26/2002 | WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | WO2002074388A1 Bisarylamines as potassium channel openers |
| 09/26/2002 | WO2002074341A1 Antipruritics |
| 09/26/2002 | WO2002055517A3 4-(hetero)aryl substituted indolinones |
| 09/26/2002 | WO2002038544A3 3-substituted oxindole beta 3 agonists |
| 09/26/2002 | WO2002036173A3 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 09/26/2002 | WO2002036116A3 Tripeptidyl peptidase inhibitors |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2001038306A9 Novel 3-nitropyridine derivatives and the pharmaceutical compositions containing said derivatives |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137937 Process for preparing [S- (R*, S*) ] -beta- [ [ [1- [1-oxo-3- (4-piperidinyl) propyl] -3-piperidinyl] carbonyl]amino] -3-pyridinepropanoic acid and derivatives |
| 09/26/2002 | US20020137933 Heterocyclic sulfonamides |
| 09/26/2002 | US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma |
| 09/26/2002 | US20020137931 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/26/2002 | US20020137771 Mixing benzimidazole derivatives with basic inorganic salt stabilizing agent, granulating and enteric coating granules; gastric acid secretion inhibitors |
| 09/26/2002 | US20020137770 Piperidine derivatives |
| 09/26/2002 | US20020137769 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
| 09/26/2002 | US20020137766 Electrophysiological activity |
| 09/26/2002 | US20020137757 Quinazolines and therapeutic use thereof |
| 09/26/2002 | US20020137747 Block cytokine production via inhibition of p38 kinase; triamino-s-triazine compounds; treating rheumatoid arthritis |
| 09/26/2002 | US20020137745 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease |
| 09/26/2002 | US20020137742 Benzenesulfonamide compounds |
| 09/26/2002 | US20020137734 N-hydroxy-2-(2-(((4-((2-methyl-4-quinolinyl)methoxy)phenyl) -sulfonyl)methyl)-2-pyrrolidinyl)acetamide, for example and other quinoline containing N-hydroxyacetamide derivatives |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |
| 09/26/2002 | US20020137664 Substituted piperidines as melanocortin-4 receptor agonists |
| 09/26/2002 | US20020137633 Herbicidal 2-pyrazolyl-6-aryloxypyri(mi)dines |
| 09/26/2002 | US20020137068 Reagents for labeling biomolecules having aldehyde or ketone Moieties |
| 09/26/2002 | US20020134984 Transition metal complex and light-emitting device |
| 09/26/2002 | DE10113402A1 New N,N'-bis-(Aminocarbonyl)-hydrazine derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, apoplexy, restenosis or tumors |
| 09/26/2002 | DE10112771A1 New 3-acylamino-3-phenyl-propionic acid derivatives, are integrin inhibitors useful e.g. for treating thrombosis, cardiac infarction, angina pectoris, tumor diseases, inflammation, osteoporosis or infections |
| 09/26/2002 | DE10112068A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site |
| 09/26/2002 | DE10100928A1 Kuppler/Entwickler- und Kuppler/Kuppler-Hybridfarbstoffe und -hybridfarbstoffvorprodukte Coupler / developer and coupler / coupler hybrid dyes and -hybridfarbstoffvorprodukte |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2442268A1 Benzimidazol derivatives modulate chemokine receptors |
| 09/26/2002 | CA2441427A1 Biurethane derivatives |
| 09/26/2002 | CA2441425A1 Antipruritics |
| 09/26/2002 | CA2440954A1 Phenyl derivatives 3 |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440405A1 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 09/26/2002 | CA2440002A1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 09/26/2002 | CA2439952A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 09/26/2002 | CA2435847A1 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | CA2430619A1 Farnesyltransferase inhibitors |
| 09/25/2002 | EP1243589A1 Heteroaryl-substituted pyrrole derivates, their preparation and their therapeutic uses |
| 09/25/2002 | EP1243583A1 Heterocyclic compounds having sulfonamide groups |
| 09/25/2002 | EP1243582A1 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/25/2002 | EP1243581A1 Pyridinium compounds useful for the treatment of AGE-related diseases |
| 09/25/2002 | EP1243579A1 Process for the production of pyridine derivatives |
| 09/25/2002 | EP1243268A1 Medicinal composition |
| 09/25/2002 | EP1242427A1 Novel piperidine and piperazine derivatives |
| 09/25/2002 | EP1242426A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 09/25/2002 | EP1242411A1 Indole derivatives for the treatment of depression and anxiety |
| 09/25/2002 | EP1242409A2 Substituted bisindolylmaleimides |
| 09/25/2002 | EP1242408A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 09/25/2002 | EP1242406A1 Novel compounds |
| 09/25/2002 | EP1242405A1 Method for producing 4-(heteroaryl-methyl)-halogen-1(2h)-phthalazinones |
| 09/25/2002 | EP1242404A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 09/25/2002 | EP1242403A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 09/25/2002 | EP1242402A2 Novel compounds |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242396A1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 09/25/2002 | EP1242385A1 Cytokine, especially tnf-alpha, inhibitors |
| 09/25/2002 | EP1242383A1 Aza compounds having neuronal activity |
| 09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
| 09/25/2002 | EP1242379A1 Curcumin analogues for treating cancer |
| 09/25/2002 | EP1242372A1 Inhibitors of farnesyl protein transferase |
| 09/25/2002 | EP1242366A1 Salicylamides as serine protease and factor xa inhibitors |
| 09/25/2002 | EP1242085A1 Benzimidazole compounds having nociceptin receptor affinity |
| 09/25/2002 | EP1242083A1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 09/25/2002 | EP1242082A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 09/25/2002 | EP1242081A1 Caspases and apoptosis |
| 09/25/2002 | EP1242076A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists |
| 09/25/2002 | EP1242075A2 Indole compounds |
| 09/25/2002 | EP1242074A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists |
| 09/25/2002 | EP1242072A1 Antipsychotic heterocycle compounds |
| 09/25/2002 | EP1242061A2 Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 09/25/2002 | EP1241943A1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 09/25/2002 | EP1073651B1 Indolyl derivatives as serotonergic agents |
| 09/25/2002 | EP1021405B1 Azetidinone derivatives for the treatment of hcmv infections |
| 09/25/2002 | EP0948485B1 Pesticidal 1-arylpyrazoles |
| 09/25/2002 | EP0923570B1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 09/25/2002 | EP0815089B1 Biphenyl-substituted triazines as light stabilizer |